Related Experiment Videos
C-reactive protein as a prognostic indicator in acute brucellosis
J M Navarro1, J Mendoza, J Leiva
1Servicio de Microbiologia, Hospital Regional Virgen de las Nieves, Granada, Spain.
Diagnostic Microbiology and Infectious Disease
|May 1, 1990
Summary
C-reactive protein (CRP) levels in acute brucellosis patients effectively predict treatment outcomes. Elevated CRP indicates a higher likelihood of an unfavorable disease course, aiding clinical management.
Area of Science:
- Infectious Diseases
- Clinical Biochemistry
Background:
- Brucellosis is a significant zoonotic infection with variable clinical presentations.
- Monitoring disease progression and treatment response in brucellosis remains a clinical challenge.
Purpose of the Study:
- To evaluate the utility of C-reactive protein (CRP) measurements in predicting the clinical course and treatment efficacy in acute brucellosis patients.
Main Methods:
- Prospective study involving 85 patients diagnosed with acute brucellosis.
- Serial measurements of CRP levels were performed before and after treatment initiation.
Main Results:
- Pre- and post-treatment CRP levels demonstrated significant predictive value for disease evolution.
- A positive CRP value ( > 1 microgram/dl) was strongly associated with an unfavorable clinical outcome, achieving a negative predictive value of 0.95.
Conclusions:
- CRP is a valuable biomarker for assessing acute brucellosis prognosis.
- Monitoring CRP levels can assist clinicians in anticipating disease trajectory and adjusting therapeutic strategies.